Global Endothelin Receptor Antagonist Sales Market Report Forecast 2017 to 2022

December 2017 | 114 pages | ID: GFFBE397CAEEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Actelion Pharmaceuticals Ltd.
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed Ltd.
GlaxoSmithKline plc
Pfizer Inc.
Reata Pharmaceuticals Inc.
Arena Pharmaceuticals Inc.

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 ENDOTHELIN RECEPTOR ANTAGONIST MARKET OVERVIEW

1.1 Product Overview and Scope of Endothelin Receptor Antagonist
1.2 Classification of Endothelin Receptor Antagonist
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Endothelin Receptor Antagonist
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Endothelin Receptor Antagonist Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Endothelin Receptor Antagonist (2012-2022)
  1.5.1 Global Endothelin Receptor Antagonist Sales and Growth Rate (2012-2022)
  1.5.2 Global Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON ENDOTHELIN RECEPTOR ANTAGONIST INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 ENDOTHELIN RECEPTOR ANTAGONIST MANUFACTURING COST ANALYSIS

3.1 Endothelin Receptor Antagonist Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Endothelin Receptor Antagonist

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Endothelin Receptor Antagonist Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Endothelin Receptor Antagonist Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL ENDOTHELIN RECEPTOR ANTAGONIST COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Endothelin Receptor Antagonist Market Competition by Manufacturers
  5.1.1 Global Endothelin Receptor Antagonist Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Endothelin Receptor Antagonist Revenue and Share by Manufacturers (2012-2017)
5.2 Global Endothelin Receptor Antagonist (Volume and Value) by Type
  5.5.1 Global Endothelin Receptor Antagonist Sales and Market Share by Type (2012-2017)
  5.5.2 Global Endothelin Receptor Antagonist Revenue and Market Share by Type (2012-2017)
5.3 Global Endothelin Receptor Antagonist (Volume and Value) by Regions
  5.3.1 Global Endothelin Receptor Antagonist Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Endothelin Receptor Antagonist Revenue and Market Share by Regions (2012-2017)
5.4 Global Endothelin Receptor Antagonist (Volume) by Application

6 UNITED STATES ENDOTHELIN RECEPTOR ANTAGONIST (VOLUME, VALUE AND SALES PRICE)

6.1 United States Endothelin Receptor Antagonist Sales and Value (2012-2017)
  6.1.1 United States Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
  6.1.2 United States Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
  6.1.3 United States Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
6.2 United States Endothelin Receptor Antagonist Sales and Market Share by Manufacturers
6.3 United States Endothelin Receptor Antagonist Sales and Market Share by Type
6.4 United States Endothelin Receptor Antagonist Sales and Market Share by Application

7 CHINA ENDOTHELIN RECEPTOR ANTAGONIST (VOLUME, VALUE AND SALES PRICE)

7.1 China Endothelin Receptor Antagonist Sales and Value (2012-2017)
  7.1.1 China Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
  7.1.2 China Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
  7.1.3 China Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
7.2 China Endothelin Receptor Antagonist Sales and Market Share by Manufacturers
7.3 China Endothelin Receptor Antagonist Sales and Market Share by Type
7.4 China Endothelin Receptor Antagonist Sales and Market Share by Application

8 EUROPE ENDOTHELIN RECEPTOR ANTAGONIST (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Endothelin Receptor Antagonist Sales and Value (2012-2017)
  8.1.1 Europe Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
  8.1.2 Europe Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
8.2 Europe Endothelin Receptor Antagonist Sales and Market Share by Manufacturers
8.3 Europe Endothelin Receptor Antagonist Sales and Market Share by Type
8.4 Europe Endothelin Receptor Antagonist Sales and Market Share by Application

9 JAPAN ENDOTHELIN RECEPTOR ANTAGONIST (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Endothelin Receptor Antagonist Sales and Value (2012-2017)
  9.1.1 Japan Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
  9.1.2 Japan Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
9.2 Japan Endothelin Receptor Antagonist Sales and Market Share by Manufacturers
9.3 Japan Endothelin Receptor Antagonist Sales and Market Share by Type
9.4 Japan Endothelin Receptor Antagonist Sales and Market Share by Application

10 GLOBAL ENDOTHELIN RECEPTOR ANTAGONIST MANUFACTURERS ANALYSIS

10.1 Actelion Pharmaceuticals Ltd.
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 United Therapeutics Corporation
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Gilead sciences
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Bayer AG
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 SteadyMed Ltd.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 GlaxoSmithKline plc
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Pfizer Inc.
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Reata Pharmaceuticals Inc.
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Arena Pharmaceuticals Inc.
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL ENDOTHELIN RECEPTOR ANTAGONIST MARKET FORECAST (2017-2022)

13.1 Global Endothelin Receptor Antagonist Sales, Revenue Forecast (2017-2022)
13.2 Global Endothelin Receptor Antagonist Sales Forecast by Regions (2017-2022)
13.3 Global Endothelin Receptor Antagonist Sales Forecast by Type (2017-2022)
13.4 Global Endothelin Receptor Antagonist Sales Forecast by Application (2017-2022)

14 APPENDIX

List Of Tables

LIST OF TABLES

Figure Picture of Endothelin Receptor Antagonist
Table Classification of Endothelin Receptor Antagonist
Figure Global Sales Market Share of Endothelin Receptor Antagonist by Type in 2016
Table Applications of Endothelin Receptor Antagonist
Figure Global Sales Market Share of Endothelin Receptor Antagonist by Application in 2016
Figure United States Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)
Figure China Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)
Figure Europe Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)
Figure Japan Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)
Figure Global Endothelin Receptor Antagonist Sales and Growth Rate (2012-2022)
Figure Global Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)
Table Global Endothelin Receptor Antagonist Sales of Key Manufacturers (2012-2017)
Table Global Endothelin Receptor Antagonist Sales Share by Manufacturers (2012-2017)
Figure 2015 Endothelin Receptor Antagonist Sales Share by Manufacturers
Figure 2016 Endothelin Receptor Antagonist Sales Share by Manufacturers
Table Global Endothelin Receptor Antagonist Revenue by Manufacturers (2012-2017)
Table Global Endothelin Receptor Antagonist Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Endothelin Receptor Antagonist Revenue Share by Manufacturers
Table 2016 Global Endothelin Receptor Antagonist Revenue Share by Manufacturers
Table Global Endothelin Receptor Antagonist Sales and Market Share by Type (2012-2017)
Table Global Endothelin Receptor Antagonist Sales Share by Type (2012-2017)
Figure Sales Market Share of Endothelin Receptor Antagonist by Type (2012-2017)
Figure Global Endothelin Receptor Antagonist Sales Growth Rate by Type (2012-2017)
Table Global Endothelin Receptor Antagonist Revenue and Market Share by Type (2012-2017)
Table Global Endothelin Receptor Antagonist Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Endothelin Receptor Antagonist by Type (2012-2017)
Figure Global Endothelin Receptor Antagonist Revenue Growth Rate by Type (2012-2017)
Table Global Endothelin Receptor Antagonist Sales and Market Share by Regions (2012-2017)
Table Global Endothelin Receptor Antagonist Sales Share by Regions (2012-2017)
Figure Sales Market Share of Endothelin Receptor Antagonist by Regions (2012-2017)
Figure Global Endothelin Receptor Antagonist Sales Growth Rate by Regions (2012-2017)
Table Global Endothelin Receptor Antagonist Revenue and Market Share by Regions (2012-2017)
Table Global Endothelin Receptor Antagonist Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Endothelin Receptor Antagonist by Regions (2012-2017)
Figure Global Endothelin Receptor Antagonist Revenue Growth Rate by Regions (2012-2017)
Table Global Endothelin Receptor Antagonist Sales and Market Share by Application (2012-2017)
Table Global Endothelin Receptor Antagonist Sales Share by Application (2012-2017)
Figure Sales Market Share of Endothelin Receptor Antagonist by Application (2012-2017)
Figure Global Endothelin Receptor Antagonist Sales Growth Rate by Application (2012-2017)
Figure United States Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
Figure United States Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
Figure United States Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
Table United States Endothelin Receptor Antagonist Sales by Manufacturers (2012-2017)
Table United States Endothelin Receptor Antagonist Market Share by Manufacturers (2012-2017)
Table United States Endothelin Receptor Antagonist Sales by Type (2012-2017)
Table United States Endothelin Receptor Antagonist Market Share by Type (2012-2017)
Table United States Endothelin Receptor Antagonist Sales by Application (2012-2017)
Table United States Endothelin Receptor Antagonist Market Share by Application (2012-2017)
Figure China Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
Figure China Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
Figure China Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
Table China Endothelin Receptor Antagonist Sales by Manufacturers (2012-2017)
Table China Endothelin Receptor Antagonist Market Share by Manufacturers (2012-2017)
Table China Endothelin Receptor Antagonist Sales by Type (2012-2017)
Table China Endothelin Receptor Antagonist Market Share by Type (2012-2017)
Table China Endothelin Receptor Antagonist Sales by Application (2012-2017)
Table China Endothelin Receptor Antagonist Market Share by Application (2012-2017)
Figure Europe Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
Figure Europe Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
Figure Europe Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
Table Europe Endothelin Receptor Antagonist Sales by Manufacturers (2012-2017)
Table Europe Endothelin Receptor Antagonist Market Share by Manufacturers (2012-2017)
Table Europe Endothelin Receptor Antagonist Sales by Type (2012-2017)
Table Europe Endothelin Receptor Antagonist Market Share by Type (2012-2017)
Table Europe Endothelin Receptor Antagonist Sales by Application (2012-2017)
Table Europe Endothelin Receptor Antagonist Market Share by Application (2012-2017)
Figure Japan Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
Figure Japan Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
Figure Japan Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
Table Japan Endothelin Receptor Antagonist Sales by Manufacturers (2012-2017)
Table Japan Endothelin Receptor Antagonist Market Share by Manufacturers (2012-2017)
Table Japan Endothelin Receptor Antagonist Sales by Type (2012-2017)
Table Japan Endothelin Receptor Antagonist Market Share by Type (2012-2017)
Table Japan Endothelin Receptor Antagonist Sales by Application (2012-2017)
Table Japan Endothelin Receptor Antagonist Market Share by Application (2012-2017)
Table Actelion Pharmaceuticals Ltd. Basic Information List
Table Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Global Market Share (2012-2017)
Table United Therapeutics Corporation Basic Information List
Table United Therapeutics Corporation Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure United Therapeutics Corporation Endothelin Receptor Antagonist Global Market Share (2012-2017)
Table Gilead sciences Basic Information List
Table Gilead sciences Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gilead sciences Endothelin Receptor Antagonist Global Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer AG Endothelin Receptor Antagonist Global Market Share (2012-2017)
Table SteadyMed Ltd. Basic Information List
Table SteadyMed Ltd. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure SteadyMed Ltd. Endothelin Receptor Antagonist Global Market Share (2012-2017)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Endothelin Receptor Antagonist Global Market Share (2012-2017)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Inc. Endothelin Receptor Antagonist Global Market Share (2012-2017)
Table Reata Pharmaceuticals Inc. Basic Information List
Table Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Global Market Share (2012-2017)
Table Arena Pharmaceuticals Inc. Basic Information List
Table Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Endothelin Receptor Antagonist
Figure Manufacturing Process Analysis of Endothelin Receptor Antagonist
Figure Endothelin Receptor Antagonist Industrial Chain Analysis
Table Raw Materials Sources of Endothelin Receptor Antagonist Major Manufacturers in 2016
Table Major Buyers of Endothelin Receptor Antagonist
Table Distributors/Traders List
Figure Global Endothelin Receptor Antagonist Sales and Growth Rate Forecast (2017-2022)
Figure Global Endothelin Receptor Antagonist Revenue and Growth Rate Forecast (2017-2022)
Table Global Endothelin Receptor Antagonist Sales Forecast by Regions (2017-2022)
Table Global Endothelin Receptor Antagonist Sales Forecast by Type (2017-2022)
Table Global Endothelin Receptor Antagonist Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Actelion Pharmaceuticals Ltd.
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed Ltd.
GlaxoSmithKline plc
Pfizer Inc.
Reata Pharmaceuticals Inc.
Arena Pharmaceuticals Inc.
Merck & Co. Inc